These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6164378)

  • 21. [On the distribution of proteinase inhibitors of broad specificity in the organs of cuttle fish (Loligo vulgaris) (author's transl)].
    Tschesche H; von Rücker A
    Hoppe Seylers Z Physiol Chem; 1973; 354(10-11):1510-2. PubMed ID: 4279880
    [No Abstract]   [Full Text] [Related]  

  • 22. [Inhibitors of plasmin-like enzymes and autofibronectin in the treatment of corneal epithelial defects].
    Polunin GS; Kasparov AA; Makarov IA; Ovchinnikov AN
    Vestn Oftalmol; 1993; 109(4):14-6. PubMed ID: 7506465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of proteinase inhibitors in snake venoms.
    Takahashi H; Iwanaga S; Suzuki T
    Toxicon; 1974 Mar; 12(2):193-7. PubMed ID: 4277439
    [No Abstract]   [Full Text] [Related]  

  • 24. Augmentation of kallikrein and plasmin inhibition capacity by aprotinin using a new assay to monitor therapy.
    Gallimore MJ; Fuhrer G; Heller W; Hoffmeister HE
    Adv Exp Med Biol; 1989; 247B():55-60. PubMed ID: 2481953
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor.
    Dubber AH; McNicol GP; Uttley D; Douglas AS
    Br J Haematol; 1968 Jan; 14(1):31-49. PubMed ID: 4229180
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic use of natural proteinase inhibitors].
    Gülzow M
    Z Gesamte Inn Med; 1969 Nov; 24(22):785-90. PubMed ID: 5308604
    [No Abstract]   [Full Text] [Related]  

  • 28. Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss.
    Flight SM; Johnson LA; Du QS; Warner RL; Trabi M; Gaffney PJ; Lavin MF; de Jersey J; Masci PP
    Br J Haematol; 2009 Apr; 145(2):207-11. PubMed ID: 19236611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The determination of natural protease inhibitors in biologic materials].
    Richter M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):130-5. PubMed ID: 4174650
    [No Abstract]   [Full Text] [Related]  

  • 30. Aprotinin in cardiac surgery.
    Sodha NR; Boodhwani M; Bianchi C; Ramlawi B; Sellke FW
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):151-60. PubMed ID: 16509811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression, purification and characterization of aprotinin and a human analogue of aprotinin.
    Sun Z; Lu W; Jiang A; Chen J; Tang F; Liu JN
    Protein Expr Purif; 2009 Jun; 65(2):238-43. PubMed ID: 19152836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of aprotinin and gabexate mesilate on human plasma kallikrein.
    Nakahara M
    Arzneimittelforschung; 1983; 33(7):969-71. PubMed ID: 6194800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties.
    Stassen JM; Lambeir AM; Matthyssens G; Ripka WC; Nyström A; Sixma JJ; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):646-54. PubMed ID: 8585001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of heparin on the kinin-forming activity of trypsin, plasmin, and various kallikreins.
    Back N; Steger R
    Proc Soc Exp Biol Med; 1970 Mar; 133(3):740-3. PubMed ID: 4244912
    [No Abstract]   [Full Text] [Related]  

  • 35. [Protease inhibitors and wound healing. Results of an double-blind study].
    Gierhake FW; Grabow L; Spitzer G; Müller C; Braun R; Hessler C; Orth HD; Skibbe G; Zimmermann K
    Chirurg; 1971 Aug; 42(8):360-3. PubMed ID: 5315262
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of the protease inhibitor aprotinin on tumor invasion of three cell lines in vitro.
    Prange E; Schroyens W; Pralle H
    Clin Exp Metastasis; 1988; 6(2):107-13. PubMed ID: 2449988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amidolytic activity in normal human plasma assessed with chromogenic substrates.
    Lämmle B; Eichlisberger R; Marbet GA; Duckert F
    Thromb Res; 1979; 16(1-2):245-54. PubMed ID: 159516
    [No Abstract]   [Full Text] [Related]  

  • 38. [Blood kallikrein-kinin system of bronchial asthma patients before and after treatment with proteinase inhibitors].
    Iasnitskaia MIa; Veremeenko KN
    Ter Arkh; 1981; 53(4):63-7. PubMed ID: 6167007
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biochemical basis for using proteolysis inhibitors in inflammatory processes of the cornea].
    Chesnokova NB; Kasavina BS; Shchipanova AI
    Vestn Oftalmol; 1983; (1):48-50. PubMed ID: 6187116
    [No Abstract]   [Full Text] [Related]  

  • 40. Proteases and antiproteasic substances in the inflammatory response.
    Bertelli A
    Biochem Pharmacol; 1968 Mar; ():Suppl:229-40. PubMed ID: 4297370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.